Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation

Rheumatology

Volumn 49, Issue 11, 2010, Pages 2076-2083

  Ciccia, Francesco ^a   Bombardieri, Michele ^b   Rizzo, Aroldo ^c   Principato, Alfonso ^a   Giardina, Anna R ^a   Raiata, Francesca ^c   Peralta, Sergio ^a   Ferrante, Angelo ^a   Drago, Sandro ^d   Cottone, Mario ^c   Pitzalis, Costantino ^b   Triolo, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Ospedali Riuniti Villa Sofia Cervello   (Italy)

^d Bionat Italia ^*  (Italy)

Author keywords

defensin 5; Ankylosing spondylitis; Intestinal inflammation; Paneth cells

Indexed keywords

ALPHA DEFENSIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CORTICOSTEROID; HUMAN ALPHA DEFENSIN 5 ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LYSOZYME; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPASE A2; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN ANTIBODY; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERITIS; FEMALE; GENE OVEREXPRESSION; GENOTYPE; HISTOPATHOLOGY; HUMAN; ILEOCOLONOSCOPY; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE; INTESTINE BIOPSY; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PANETH CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; FEMALE; GASTROENTERITIS; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PANETH CELLS; SPONDYLITIS, ANKYLOSING;

EID: 78649354905     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq239     Document Type: Article

References (33)

1. Ciccia F, Bombardieri M, Princicpato A et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 2009;60:955-65.
2. De Vos M, Mielants H, Cuvelier C et al. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 1996;110:1696-703.
3. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94.
4. Stebbings SM, Taylor C, Tannock GW et al. The immune response to autologous bacteroides in ankylosing spondylitis is chacacterized by reduced interleukin 10 production. J Rheumatol 2009;36:797-800.
5. Mielants H, Veys EM, Cuvelier C, De Vos M. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;27(Suppl 2):95-105.
6. Van Damme N, Elewaut D, Baeten D et al. Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin. Clin Exp Rheumatol 2001;19:681-7.
7. Van Damme N, De Vos M, Baeten D et al. Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy. Ann Rheum Dis 2001;60:495-9.
8. Wehkamp J, Chu H, Shen B et al. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett 2006;580: 5344-50.
9. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J Leukoc Biol 2006;80: 500-8.
10. Simms LA, Doecke JD, Walsh MD et al. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008;57:903-10.
11. Wehkamp J, Salzman NH, Porter E et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 2005;102:18129-34.
12. Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004;53:1658-64.
13. Hampe J, Grebe J, Nikolaus S et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002;359: 1661-5.
14. Lala S, Ogura Y, Osborne C et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003;125:47-57.
15. Ogura Y, Lala S, Xin W et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003;52: 1591-7.
16. Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007;39:207-11.
17. Cadwell K, Liu JY, Brown SL et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008;456: 259-63.
18. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009;58:1152-67.
19. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
20. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
21. Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
22. Nevalainen TJ, Haapanen TJ. Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues. Inflammation 1993;17:453-64.
23. Bastide P, Darido C, Pannequin J et al. Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 2007;178: 635-48.
24. Mori-Akiyama Y, van den Born M, van Es JH et al. SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 2007;133:539-46.
25. Szyk A, Wu Z, Tucker K et al. Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci 2006; 15:2749-60.
26. Lehrer RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993;11:105-28.
27. Bevins CL, Martin-Porter E, Ganz T. Defensins and innate host defence of the gastrointestinal tract. Gut 1999;45: 911-5.
28. Grigat J, Soruri A, Forssmann U et al. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 2007;179:3958-65.
29. Shi J, Aono S, Lu W et al. A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion. J Immunol 2007;179:1245-53.
30. Lin PW, Simon PO Jr, Gewirtz AT et al. Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J Biol Chem 2004;279: 19902-7.
31. Kufer TA, Banks DJ, Philpott DJ. Innate immune sensing of microbes by Nod proteins. Ann NY Acad Sci 2006;1072: 19-27.
32. Ogura Y, Inohara N, Benito A et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276: 4812-8.
33. Crane AM, Bradbury L, van Heel DA et al. Role of NOD2 variants in spondylarthritis. Arthritis Rheum 2002;46: 1629-33.